Tag Archives: healthcare

The Convergence of BioPharma and Digital Medicine

Dr. Eric Topol

Our newfound capability of digitizing the medical essence of human beings with biosensors, imaging, sequencing and other biologic omics (A “Google Medical Map” of Each Individual) will be the foundation for a new era of medicine — one that is datafied and democratized. Most of the leading biopharma companies have already begun to embrace digital medicine, through partnerships with online health communities, particularly Patients Like Me or via biosensors in a variety of conditions including Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Out of Africa: Biomedical Innovation and Expertise


Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden of disease on the world’s populations. Developing countries, such as those in sub-Saharan Africa, are disproportionately encumbered by disease – many of which are endemic only to those geographies.  Yet these same regions are a wellspring of innovative and creative ideas that are being used to advance biomedical science and healthcare product development. Research centers within these regions are yet Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About ‘Big Pharma’


This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big myths about big pharma in this Forbes opinion piece. He points to these five biggest industry myths as ‘routinely poisoning debates, obscuring genuine problems, and distorting policy recommendations on health care.’ In short (excerpts): Myth #1 Pharmaceutical companies exaggerate the costs of developing new medicines to justify high prices. In fact: The research and development (R&D) expenditures of this industry Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Leading MIT Scientist, Professor and Entrepreneur, Robert Langer, to Speak at BIO 2015

BIO International Convention

In a recent Boston Globe article, MIT standout and Queen Elizabeth Prize for Engineering recipient, Robert Langer, discusses the highlights and challenges facing our industry. He emphasized all of the progressive work being done on the drug-delivery system, collaborations with the Bill Gates foundation for the Third World and the work on nanotechs in the lab, specifically trying to deliver different kinds of gene therapy and drugs in general. “There’s so much great work going Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

United Health To Congress: Let Cancer Patients Eat Gauze (Op-Ed in The Hill)


Jonathan Wilcox’s op-ed in The Hill today highlights the growing challenge of insurance company tactics that contribute to increased costs to the health care system and restricted patient access to life-saving medicines. While UnitedHealth Group just reported increased revenues for first quarter 2015, patients are shouldering the burden with rising copays and restricted coverage, asserts the author. As Wilcox writes, ‘That’s why cancer advocacy organizations are taking action, pressing Congress and state legislatures to cap co-pays on specialty Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,